RA CAPITAL MANAGEMENT, L.P. — Form 4 insider transactions
RA CAPITAL MANAGEMENT, L.P. — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-11-02 | Buy | Bambusa Therapeutics, Inc. | 164,891 | $16.00 | $2,638,256 | SEC filing |
| 2026-11-02 | Buy | Bambusa Therapeutics, Inc. | 2,335,109 | $16.00 | $37,361,744 | SEC filing |
| 2026-11-02 | Conversion | Bambusa Therapeutics, Inc. | 1,331,080 | — | — | SEC filing |
| 2026-11-02 | Conversion | Bambusa Therapeutics, Inc. | 3,144,858 | — | — | SEC filing |
| 2026-10-30 | Buy | Bambusa Therapeutics, Inc. | 263,911 | $14.92 | $3,937,552 | SEC filing |
| 2026-10-30 | Buy | Bambusa Therapeutics, Inc. | 189,909 | $14.23 | $2,702,405 | SEC filing |
| 2026-10-29 | Sell | LENZ Therapeutics, Inc. | 107,170 | $3.36 | $360,091 | SEC filing |
| 2026-10-29 | Sell | LENZ Therapeutics, Inc. | 451,998 | $3.36 | $1,518,713 | SEC filing |
| 2026-10-29 | Sell | LENZ Therapeutics, Inc. | 2,159,516 | $3.36 | $7,255,974 | SEC filing |
| 2026-10-05 | Award | Wave Life Sciences, Inc. | 10,700 | — | — | SEC filing |
| 2026-10-02 | Opt exercise | Vor Biopharma Inc. | 500 | $12.80 | $6,400 | SEC filing |
| 2026-09-28 | Opt exercise | Climb Bio, Inc. | 40,000 | $1.29 | $51,600 | SEC filing |
| 2026-09-28 | Opt exercise | Climb Bio, Inc. | 10,000 | $7.89 | $78,900 | SEC filing |
| 2026-09-28 | Opt exercise | Climb Bio, Inc. | 10,000 | $3.00 | $30,000 | SEC filing |
| 2026-09-28 | Opt exercise | Climb Bio, Inc. | 10,000 | $3.46 | $34,600 | SEC filing |
| 2026-09-17 | Sell | Sionna Therapeutics, Inc. | 33,800 | $7.46 | $252,148 | SEC filing |
| 2026-09-17 | Sell | Sionna Therapeutics, Inc. | 3,415,011 | $6.32 | $21,582,870 | SEC filing |
| 2026-08-24 | Opt exercise | Vor Biopharma Inc. | 1,500 | $3.74 | $5,604 | SEC filing |
| 2026-08-12 | Sell | Septerna, Inc. | 746,500 | $42.50 | $31,726,250 | SEC filing |
| 2026-07-31 | Buy | Artiva Biotherapeutics, Inc. | 24,944 | $9.93 | $247,694 | SEC filing |
| 2026-07-29 | J | Inhibikase Therapeutics, Inc. | 18,030,000 | — | — | SEC filing |
| 2026-07-29 | Buy | Artiva Biotherapeutics, Inc. | 20,824 | $9.99 | $208,032 | SEC filing |
| 2026-07-24 | Buy | Artiva Biotherapeutics, Inc. | 41,319 | $9.99 | $412,777 | SEC filing |
| 2026-07-23 | Buy | Artiva Biotherapeutics, Inc. | 59,880 | $9.96 | $596,405 | SEC filing |
| 2026-07-22 | Buy | Artiva Biotherapeutics, Inc. | 84,124 | $9.93 | $835,351 | SEC filing |
| 2026-07-21 | Buy | Artiva Biotherapeutics, Inc. | 120,582 | $9.55 | $1,151,558 | SEC filing |
| 2026-07-13 | Buy | Artiva Biotherapeutics, Inc. | 6,522 | $8.94 | $58,307 | SEC filing |
| 2026-07-22 | Buy | Parabilis Medicines, Inc. | 47,250 | $29.77 | $1,406,632 | SEC filing |
| 2026-07-21 | Buy | Parabilis Medicines, Inc. | 37,723 | $30.00 | $1,131,690 | SEC filing |
| 2026-07-21 | Buy | Parabilis Medicines, Inc. | 6,504 | $29.17 | $189,722 | SEC filing |
| 2026-07-21 | Buy | Parabilis Medicines, Inc. | 21,696 | $27.96 | $606,620 | SEC filing |
| 2026-07-20 | Buy | Parabilis Medicines, Inc. | 32,987 | $27.72 | $914,400 | SEC filing |
| 2026-07-20 | Buy | Parabilis Medicines, Inc. | 98,433 | $27.13 | $2,670,487 | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 336,965 | $10.00 | $3,369,650 | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 4,918,411 | $10.00 | $49,184,110 | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 367,427 | — | — | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 908,103 | — | — | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 553,703 | — | — | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 970,950 | — | — | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 6,561,711 | — | — | SEC filing |
| 2026-07-16 | Sell | Vor Biopharma Inc. | 213 | $19.75 | $4,207 | SEC filing |
| 2026-07-16 | Opt exercise | Vor Biopharma Inc. | 2,100,000 | $0.00 | $4,200 | SEC filing |
| 2026-07-17 | Buy | Artiva Biotherapeutics, Inc. | 7,882 | $8.95 | $70,544 | SEC filing |
| 2026-07-16 | Buy | Artiva Biotherapeutics, Inc. | 152,472 | $8.93 | $1,361,575 | SEC filing |
| 2026-07-13 | Buy | Artiva Biotherapeutics, Inc. | 6,552 | $8.94 | $58,575 | SEC filing |
| 2026-07-10 | Buy | Artiva Biotherapeutics, Inc. | 15,102 | $8.97 | $135,465 | SEC filing |
| 2026-06-26 | Buy | Artiva Biotherapeutics, Inc. | 1,876 | $8.98 | $16,846 | SEC filing |
| 2026-06-25 | Buy | Artiva Biotherapeutics, Inc. | 31,000 | $8.88 | $275,280 | SEC filing |
| 2026-06-17 | Sell | Werewolf Therapeutics, Inc. | 27,695 | $0.35 | $9,693 | SEC filing |
| 2026-06-17 | Sell | Werewolf Therapeutics, Inc. | 389,216 | $0.35 | $136,226 | SEC filing |
| 2026-06-16 | Buy | Hemab Therapeutics Holdings, Inc. | 61,523 | $24.98 | $1,536,845 | SEC filing |
| 2026-06-15 | Buy | Hemab Therapeutics Holdings, Inc. | 6,146 | $24.89 | $152,974 | SEC filing |
| 2026-06-16 | Sell | Werewolf Therapeutics, Inc. | 9,939 | $0.37 | $3,677 | SEC filing |
| 2026-06-16 | Sell | Werewolf Therapeutics, Inc. | 139,686 | $0.37 | $51,684 | SEC filing |
| 2026-06-16 | Buy | Artiva Biotherapeutics, Inc. | 124,893 | $8.89 | $1,110,299 | SEC filing |
| 2026-06-15 | Sell | Werewolf Therapeutics, Inc. | 8,554 | $0.39 | $3,336 | SEC filing |
| 2026-06-15 | Sell | Werewolf Therapeutics, Inc. | 120,216 | $0.39 | $46,884 | SEC filing |
| 2026-06-15 | Buy | Artiva Biotherapeutics, Inc. | 15,414 | $8.99 | $138,572 | SEC filing |
| 2026-06-12 | Sell | Werewolf Therapeutics, Inc. | 11,322 | $0.40 | $4,529 | SEC filing |
| 2026-06-12 | Sell | Werewolf Therapeutics, Inc. | 159,119 | $0.40 | $63,648 | SEC filing |
| 2026-06-12 | Buy | Artiva Biotherapeutics, Inc. | 391,019 | $8.57 | $3,351,033 | SEC filing |
| 2026-06-11 | Buy | Parabilis Medicines, Inc. | 1,460,397 | $20.00 | $29,207,940 | SEC filing |
| 2026-06-11 | Buy | Parabilis Medicines, Inc. | 19,728,353 | $20.00 | $394,567,060 | SEC filing |
| 2026-06-11 | Conversion | Parabilis Medicines, Inc. | 1,187,881 | — | — | SEC filing |
| 2026-06-11 | Conversion | Parabilis Medicines, Inc. | 6,556,740 | — | — | SEC filing |
| 2026-06-11 | Award | Janux Therapeutics, Inc. | 5,500 | — | — | SEC filing |
| 2026-06-11 | Buy | Artiva Biotherapeutics, Inc. | 548,580 | $7.91 | $4,339,268 | SEC filing |
| 2026-06-11 | Sell | Werewolf Therapeutics, Inc. | 17,437 | $0.38 | $6,626 | SEC filing |
| 2026-06-11 | Sell | Werewolf Therapeutics, Inc. | 245,066 | $0.38 | $93,125 | SEC filing |
| 2026-06-10 | Buy | Artiva Biotherapeutics, Inc. | 103 | $7.00 | $721 | SEC filing |
| 2026-06-10 | Sell | Werewolf Therapeutics, Inc. | 3,051 | $0.37 | $1,129 | SEC filing |
| 2026-06-10 | Sell | Werewolf Therapeutics, Inc. | 42,872 | $0.37 | $15,863 | SEC filing |
| 2026-06-09 | Buy | Artiva Biotherapeutics, Inc. | 479,039 | $6.91 | $3,310,159 | SEC filing |
| 2026-06-09 | Sell | Werewolf Therapeutics, Inc. | 24,565 | $0.37 | $9,089 | SEC filing |
| 2026-06-09 | Sell | Werewolf Therapeutics, Inc. | 345,235 | $0.37 | $127,737 | SEC filing |
| 2026-06-03 | Award | Acumen Pharmaceuticals, Inc. | 35,500 | — | — | SEC filing |
| 2026-05-20 | Buy | Hemab Therapeutics Holdings, Inc. | 996 | $24.94 | $24,840 | SEC filing |
| 2026-05-19 | Buy | Hemab Therapeutics Holdings, Inc. | 3,802 | $24.97 | $94,936 | SEC filing |
| 2026-05-18 | Award | Acrivon Therapeutics, Inc. | 9,366 | — | — | SEC filing |
| 2026-05-12 | Buy | Hemab Therapeutics Holdings, Inc. | 6,387 | $24.90 | $159,036 | SEC filing |
| 2026-05-11 | Buy | Artiva Biotherapeutics, Inc. | 6,510,416 | $11.52 | $74,999,992 | SEC filing |
| 2026-05-12 | Sell | Werewolf Therapeutics, Inc. | 6,719 | $0.64 | $4,300 | SEC filing |
| 2026-05-12 | Sell | Werewolf Therapeutics, Inc. | 94,432 | $0.64 | $60,436 | SEC filing |
| 2026-05-11 | Sell | Werewolf Therapeutics, Inc. | 5,812 | $0.67 | $3,894 | SEC filing |
| 2026-05-11 | Sell | Werewolf Therapeutics, Inc. | 81,678 | $0.67 | $54,724 | SEC filing |
| 2026-05-08 | Sell | Werewolf Therapeutics, Inc. | 25,012 | $0.71 | $17,759 | SEC filing |
| 2026-05-08 | Sell | Werewolf Therapeutics, Inc. | 351,514 | $0.71 | $249,575 | SEC filing |
| 2026-05-11 | Buy | Hemab Therapeutics Holdings, Inc. | 25,720 | $25.00 | $643,000 | SEC filing |
| 2026-05-11 | Buy | Hemab Therapeutics Holdings, Inc. | 14,149 | $24.47 | $346,226 | SEC filing |
| 2026-05-08 | Buy | Hemab Therapeutics Holdings, Inc. | 1,483 | $24.98 | $37,045 | SEC filing |
| 2026-05-07 | Buy | Hemab Therapeutics Holdings, Inc. | 1,985 | $24.95 | $49,526 | SEC filing |
| 2026-05-07 | Buy | Hemab Therapeutics Holdings, Inc. | 7,921 | $24.34 | $192,797 | SEC filing |
| 2026-05-06 | Buy | Hemab Therapeutics Holdings, Inc. | 53,407 | $24.83 | $1,326,096 | SEC filing |
| 2026-05-06 | Buy | Hemab Therapeutics Holdings, Inc. | 14,611 | $23.77 | $347,303 | SEC filing |
| 2026-05-05 | Buy | Hemab Therapeutics Holdings, Inc. | 10,268 | $25.00 | $256,700 | SEC filing |
| 2026-05-05 | Buy | Hemab Therapeutics Holdings, Inc. | 87,143 | $24.59 | $2,142,846 | SEC filing |
| 2026-05-04 | Buy | Hemab Therapeutics Holdings, Inc. | 133,750 | $18.00 | $2,407,500 | SEC filing |
| 2026-05-04 | Buy | Hemab Therapeutics Holdings, Inc. | 2,541,250 | $18.00 | $45,742,500 | SEC filing |
| 2026-05-04 | Conversion | Hemab Therapeutics Holdings, Inc. | 221,188 | — | — | SEC filing |
| 2026-05-04 | Conversion | Hemab Therapeutics Holdings, Inc. | 1,009,052 | — | — | SEC filing |
| 2026-05-04 | Conversion | Hemab Therapeutics Holdings, Inc. | 3,607,846 | — | — | SEC filing |
| 2026-04-27 | J | Adicet Bio, Inc. | 250,000 | — | — | SEC filing |
| 2026-04-27 | J | Prelude Therapeutics Inc | 1,407,000 | — | — | SEC filing |
| 2026-04-22 | Sell | Vor Biopharma Inc. | 165,150 | $15.77 | $2,604,416 | SEC filing |
| 2026-04-22 | Award | Acrivon Therapeutics, Inc. | 3,888,888 | $1.80 | $6,999,998 | SEC filing |
| 2026-04-20 | Sell | Vor Biopharma Inc. | 171,963 | $15.77 | $2,711,857 | SEC filing |
| 2026-04-17 | Sell | Vor Biopharma Inc. | 458,411 | $16.28 | $7,462,931 | SEC filing |
| 2026-04-15 | Sell | Vor Biopharma Inc. | 53,644 | $16.01 | $858,840 | SEC filing |
| 2026-04-14 | Sell | Vor Biopharma Inc. | 153,735 | $15.97 | $2,455,148 | SEC filing |
| 2026-04-13 | Sell | Vor Biopharma Inc. | 530,610 | $16.15 | $8,569,352 | SEC filing |
| 2026-02-20 | Buy | Adicet Bio, Inc. | 74,751 | $7.27 | $543,440 | SEC filing |
| 2026-02-19 | Buy | Adicet Bio, Inc. | 74,268 | $7.21 | $535,472 | SEC filing |
| 2026-02-18 | Buy | Adicet Bio, Inc. | 74,577 | $7.04 | $525,022 | SEC filing |
| 2026-04-10 | Sell | Vor Biopharma Inc. | 828 | $15.75 | $13,041 | SEC filing |
| 2026-04-09 | Sell | Vor Biopharma Inc. | 135,201 | $16.59 | $2,242,985 | SEC filing |
| 2026-04-08 | Sell | Vor Biopharma Inc. | 130,862 | $16.91 | $2,212,876 | SEC filing |
| 2026-04-08 | Sell | Vor Biopharma Inc. | 353,242 | $16.32 | $5,764,909 | SEC filing |
| 2026-04-06 | Sell | Vor Biopharma Inc. | 6,775 | $18.50 | $125,338 | SEC filing |
| 2026-04-06 | Sell | Vor Biopharma Inc. | 44,728 | $17.31 | $774,242 | SEC filing |
| 2026-04-06 | Sell | Vor Biopharma Inc. | 537,754 | $16.51 | $8,878,319 | SEC filing |
| 2026-04-02 | Sell | Vor Biopharma Inc. | 1,525 | $19.06 | $29,066 | SEC filing |
| 2026-04-02 | Sell | Vor Biopharma Inc. | 258,475 | $18.23 | $4,711,999 | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.